Corporate information

Registration country

Company type

Orphazyme develops innovative new therapies for the treatment of a family of serious genetic disordes called lysosomal storage diseases.

Funding rounds

Series A USD 20,000,000


USD 20,000,000 ( )

Profile Country
Aescap Venture Management BV Venture capital company investing in private medical companies in Europe
Novo A/S
Sunstone Capital AS

Seed


( )



Investment activity status
Active investor

Current team

Past employees

Selected Products / Customers

Financials